CurveBeam AI (ASX:CVB) Net Income From Continuing Operations: A$-18.83 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is CurveBeam AI Net Income From Continuing Operations?

CurveBeam AI ASX:CVB +13.64% Net Income From Continuing Operations is A$-18.83 Mil as of Jun. 2026. The stock has 8 warning signs investors should review.

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. CurveBeam AI's net income from continuing operations for the six months ended in Jun. 2026 was A$-8.99 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jun. 2026 was A$-18.83 Mil.

CurveBeam AI Net Income From Continuing Operations Historical Data

* Premium members only.

The historical data trend for CurveBeam AI's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CurveBeam AI Net Income From Continuing Operations Chart

CurveBeam AI Annual Data
Trend Jun22 Jun23 Jun24 Jun25 Jun26
Net Income From Continuing Operations
-8.54 -51.23 -23.10 -16.84 -18.83

CurveBeam AI Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Net Income From Continuing Operations Get a 7-Day Free Trial -8.93 -10.52 -6.32 -9.84 -8.99

CurveBeam AI Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-18.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Income From Continuing Operations of A$-18.83 Mil mean?
CurveBeam AI (ASX:CVB) has a Net Income From Continuing Operations of A$-18.83 Mil as of Jun. 2026. The total net income from continuing operations as record on a company's cash-flow statement. View historical data for CurveBeam AI and its competitors.
Is CurveBeam AI's Net Income From Continuing Operations too high?
CurveBeam AI's current Net Income From Continuing Operations is A$-18.83 Mil.
How does CurveBeam AI's Net Income From Continuing Operations compare to ABT and SYK?
CurveBeam AI's Net Income From Continuing Operations of A$-18.83 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income From Continuing Operations for a Medical Devices & Instruments company?
A good Net Income From Continuing Operations depends on the Medical Devices & Instruments industry context. However, Net Income From Continuing Operations should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income From Continuing Operations mean?
A high Net Income From Continuing Operations can signal that a stock is expensive relative to its fundamentals. The total net income from continuing operations as record on a company's cash-flow statement. View historical data for CurveBeam AI and its competitors. CurveBeam AI's current Net Income From Continuing Operations is A$-18.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CurveBeam AI stock overvalued right now?
Based on GuruFocus' analysis, CurveBeam AI (ASX:CVB) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.06, compared to a current price of A$0.03 — trading 58.3% below its estimated fair value. The current Net Income From Continuing Operations is A$-18.83 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income From Continuing Operations calculated?
Net Income From Continuing Operations is calculated from a company's financial statements. For CurveBeam AI (ASX:CVB), the current Net Income From Continuing Operations is A$-18.83 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CurveBeam AI Business Description

Address 10 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.